Liver‐related mortality · people with chronic liver diseases
It is very uncertain whether vitamin D changes liver‐related mortality compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Serious adverse events · people with chronic liver diseases
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Liver morbidity · people with chronic liver diseases
1 finding from 1 review
Health‐related quality of life · people with chronic liver diseases
1 finding from 1 review
Non‐serious adverse events · people with chronic liver diseases
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Failure of sustained virological response · people with chronic liver diseases
It is very uncertain whether vitamin D changes failure of sustained virological response compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Serum 25-hydroxyvitamin D level · people with sickle cell disease
1 finding from 1 review
Total body BMD measured by DEXA (% change from baseline) · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with sickle cell disease
Vitamin D showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Pain frequency or change in pain frequency · people with sickle cell disease
1 finding from 1 review
Acute chest syndrome ( · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Respiratory infections · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HRQoL score (physical functioning) (change from baseline) · people with sickle cell disease
1 finding from 1 review
Linear growth (length/height) Unit: cm Time frame: 3 months · children under 5 years of age
1 finding from 1 review
Mean height‐for‐age z‐score · children under 5 years of age
1 finding from 1 review
Stunting · children under 5 years of age
Vitamin D showed no clear difference in stunting Definition: L/HAZ < ‐2Time frame: 6 months compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
Adverse effect: hypercalciuria As defined by trialists Time frame: 3 months · children under 5 years of age
Vitamin D showed no clear difference in adverse effect: hypercalciuria As defined by trialistsTime frame:… compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
Hypercalcaemia · children under 5 years of age
It is very uncertain whether vitamin D changes adverse effect: hypercalcaemia As defined by trialistsTime frame:… compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse effect: hyperphosphataemiae · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effect: kidney stonesb · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found